E Ogris Selected Research

Lymph Node Excision (Lymph Node Dissection)

1/2002

[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Ogris Research Topics

Disease

2	Neoplasms (Cancer) 11/2009 - 01/2002
2	Breast Neoplasms (Breast Cancer) 01/2002 - 08/2000
1	Colonic Neoplasms (Colon Cancer) 11/2009
1	Residual Neoplasm 11/2009
1	Nausea 12/2004
1	Appendicitis 12/2004
1	Vomiting 12/2004
1	Abdominal Pain (Pain, Abdominal) 12/2004

Drug/Important Bio-Agent (IBA)

1	Keratin-18 (Keratin 18)IBA 11/2009
1	Keratins (Keratin)IBA 11/2009
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	CaspasesIBA 11/2009
1	ProcalcitoninIBA 12/2004
1	C-Reactive ProteinIBA 12/2004
1	ProlactinIBA 08/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2009 - 08/2000
1	Therapeutics 01/2002
1	Lymph Node Excision (Lymph Node Dissection) 01/2002
1	Immunotherapy 08/2000
1	Stem Cell Transplantation 08/2000
1	Autologous Transplantation 08/2000